Vaxine
Chemicals & Related Products · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Flinders Dr, Bedford Park, South Austr...Phone Number
+61 882044572Website
www.vaxine.netRevenue
<$5 MillionIndustry
About Vaxine
Vaxine is a leading Australian biotechnology company based in Adelaide, specializing in the development of vaccines and immunotherapies. Their product portfolio includes vaccines for Covid-19, influenza, hepatitis B, and Japanese encephalitis, as well as immunotherapies targeting allergies and cancer. The company leverages advanced adjuvant technology and artificial intelligence to enhance vaccine efficacy and speed up drug design. Vaxine aims to improve global health outcomes and is actively involved in clinical trials and research initiatives.Explore more
Vaxine Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Vaxine
Compare insights from companies similar to Vaxine, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Vaxine
<$5M
11-50
Private
-
2002
TS
Thillai SathiyaseelanManager, Research , Vaccine Development Projects (Part-Time)
Vaxine Tech Stack
A closer look at the technologies used by Vaxine
See more technologies
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Vaxine
Sign Up For FreeTo access detailed company insights
Vaxine is a leading Australian biotechnology company based in Adelaide, specializing in the development of vaccines and immunotherapies. Their product portfolio includes vaccines for Covid-19, influenza, hepatitis B, and Japanese encephalitis, as well as immunotherapies targeting allergies and cancer. The company leverages advanced adjuvant technol... Read More
